The effectiveness of a new intranasal steroid Avamys in seasonal allergic rhinitis
About the authors
Saratov State Medical University
- Bousquet J., Khaltaev N., Cruz A.A. et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy. 2008, Apr, 63, Suppl, v. 86, p. 8-160.
- Allen A et al. Absolute Bioavailability of Intranasal Fluticasone Furoate in Healthy Subjects Clin Ther. 2007, v. 29, p. 1415-1420.
- Derendorf H, Meltzer E.O. Molecular and clinical pharmacology of intranasal corticosteroids: clinical and therapeutic implications. Allergy. 2008, v. 63, p. 1292-1300.
- Valotis A., Hogger P. Human receptor kinetics and lung tissue retention of the enhanced-affmity glucocorticoid fluticasone furoate. Respir. Res. 2007, v. 8, p. 54-62.
- Fokkens W., Jogi R., Reinartz S. et al. Once daily fluticasone furoate nasal spray is effective in seasonal allergic rhinitis caused by grass pollen. Allergy. 2007, v. 62, p. 1078-1084.
- Kaiser H.B., Nacleiro R.M., Given J. et al. Fluticasone furoate nasal spray: A single treatment option for the symptoms of seasonal allergic rhinitis J. Allergy Clin. Immunol. 2007, v. 119, p. 1430-1437.
- Jacobs R., Martin В., Hampel F. et al. Fluticasone furoate 110 ug once daily is effective against the nasal and ocular symptoms of seasonal allergic rhinitis in adults and adolescents sensitized to mountain cedar pollen Curr. Med. Res. Opin. 2009, v. 25, p. 1393-1401.
- Canonica G. et al. A survey of the burden of allergic rhinitis in Europe. Allergy. 2007, v. 62 (Suppl 85), p. 17-25.
- Scadding G, Punekar Y. EAACI 2006, Abstracts 741 and 1660.
- Keith R, Scadding G. Are intranasal corticosteroids all equally consistent in managing ocular symptoms of seasonal allergic rhinitis? Curr. Med. Res. Opin. 2009, v. 25 (8).